We are live on ! Find out more
MDCXW

Medicus Pharma Warrant

6 hedge funds and large institutions have $187K invested in Medicus Pharma Warrant in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AFM
1
Anson Funds Management
Texas
$103K +$27.2K +42,400 New
CS
2
Clear Street
New York
$36K +$26.4K +41,270 New
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$26.9K +$26.5K +41,300 New
WAM
4
Warberg Asset Management
Illinois
$18K +$17.6K +27,470 New
CCM
5
Connective Capital Management
California
$2.11K +$3.84K +6,000 New
UBS Group
6
UBS Group
Switzerland
$702 +$1.28K +2,000 New

MDCXW Hedge Fund Activity: Q4 2024 in Review

6 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q4 2024, worth a combined $187K.

Buyers outnumbered sellers: 6 funds opened new MDCXW positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $27.2K.

  • 6 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q4 2024, up from 0 in Q3 2024.
  • Funds reported $187K of Medicus Pharma Warrant stock for Q4 2024.
  • 6 funds opened new Medicus Pharma Warrant positions in Q4 2024 and 0 closed out, a net change of +6 holders.
  • The largest Medicus Pharma Warrant buyer in Q4 2024 was Anson Funds Management, an estimated $27.2K added.

Based on aggregated 13F filings for Q4 2024.